Skip to main content
CNC
NYSE Finance

Centene Reports Strong Q1 Earnings Beat, Raises Full-Year EPS and Revenue Guidance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare
Sentiment info
Positive
Importance info
8
Price
$45
Mkt Cap
$21.397B
52W Low
$25.075
52W High
$64.15
52W Position info
79% above low
Off High info
30% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

CNC sits 79% above its 52-week low of $25.075.

Summary

Centene reported Q1 adjusted EPS of $3.37, beating expectations, and raised its full-year adjusted EPS guidance to over $3.40, alongside an increased revenue outlook and $1.0 billion in debt reduction.


Key Events · Earnings and Guidance · CNC

  • Strong Q1 Financial Outperformance

    Reported Q1 2026 GAAP diluted EPS of $3.11 and adjusted diluted EPS of $3.37, with the adjusted figure approximately $0.50 better than expectations. Total revenues reached $49.944 billion.

  • Increased Full-Year Guidance

    Raised 2026 GAAP diluted EPS guidance to greater than $2.37 and adjusted diluted EPS guidance to greater than $3.40. Full-year premium and service revenues guidance was increased by $1.0 billion to a range of $171.0 billion to $175.0 billion.

  • Significant Debt Reduction

    Achieved $1.0 billion in debt reduction during the first quarter of 2026 through the repurchase of senior notes.

  • Improved Profitability Metrics

    The Health Benefits Ratio (HBR) decreased to 87.3% from 87.5% in Q1 2025, and the adjusted SG&A expense ratio improved to 7.6% from 7.9%, reflecting strong cost management and leveraging of expenses.


Analysis · CNC · Finance

Centene Corporation delivered robust first-quarter results, significantly exceeding adjusted EPS expectations by approximately $0.50. The company also raised its full-year adjusted EPS guidance to greater than $3.40 and increased its premium and service revenue outlook by $1.0 billion. This positive financial performance, coupled with a $1.0 billion debt reduction and improved health benefits and SG&A expense ratios, signals strong progress in margin recovery efforts and operational efficiency, especially following the substantial GAAP net loss reported in the prior fiscal year.

At the time of this filing, CNC was trading at $45.00 on NYSE in the Finance sector, with a market capitalization of approximately $21.4B. The 52-week trading range was $25.08 to $64.15. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CNC - Latest Insights

CNC
Jul 29, 2026, 3:15 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $62.51
Real-time Price: $59.99 info
Change: -$2.52 (-4%) info
Market Cap: $31.559B info
CNC
Jul 28, 2026, 7:34 AM EDT
Source: dpa-AFX
Importance Score:
8
Price at Filing: $65.30
Real-time Price: $59.99 info
Change: -$5.31 (-8%) info
Market Cap: $31.559B info
CNC
Jul 28, 2026, 6:28 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $65.00
Real-time Price: $59.99 info
Change: -$5.01 (-8%) info
Market Cap: $31.559B info
CNC
Jul 28, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $67.38
Real-time Price: $59.99 info
Change: -$7.39 (-11%) info
Market Cap: $31.559B info
CNC
Jul 27, 2026, 7:38 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $67.38
Real-time Price: $59.99 info
Change: -$7.39 (-11%) info
Market Cap: $31.559B info